Navigation Links
Urocidin™ Phase III Clinical Trial Results Presented at AUA Conference in Washington, D.C.
Date:5/17/2011

CHADDS FORD, Pa. and BELLEVILLE, Ontario, May 17, 2011 /PRNewswire/ -- Endo Pharmaceuticals and Bioniche Life Sciences today presented Phase III trial results for the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™, during a podium presentation at the 2011 American Urological Association annual meeting in Washington, D.C. The preliminary results from the interim analysis of this prospective trial indicate that Urocidin™ may provide an alternative to cystectomy for patients with bacillus Calmette-Guerin (BCG) refractory non-muscle invasive bladder cancer (NMIBC).

The preliminary results were generated from an interim analysis in an ongoing Phase III trial with Urocidin™ in the treatment of NMIBC that is refractory to BCG and at high risk of progression.

The Results

A total of 129 patients were enrolled from 25 centers in the U.S. and Canada, with high grade papillary tumors and/or carcinoma in situ (CIS) and having failed to respond to one or more courses of BCG. According to the preliminary results the overall one-year disease-free survival (DFS) rate was 25 percent. DFS is defined as lack of recurrence or progression to muscle-invasive disease, as confirmed by biopsy. The one-year DFS rate was 35 percent for patients with only papillary tumors and 21 percent for patients with carcinoma in situ (CIS) with or without papillary tumors. The preliminary results indicate that intravesical administration of Urocidin™ was well tolerated.

Ongoing Phase III Clinical Program with Urocidin™

Summary details of a Phase III clinical trial protocol with Urocidin™ being conducted by Endo are publicly available via the U.S. National Institutes of Health (NIH) clinical trial registration service at http://www.clinicaltrials.gov. This trial is active
'/>"/>

SOURCE Endo Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Urocidin™ Phase III Clinical Trial Results to be Presented at EAU and AUA Conferences
2. Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting
3. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
4. Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan
5. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
6. Independent Investigator Initiates Phase 1 Study of Biodels Ultra-Rapid-Acting Insulin Formulations in Patients Using Insulin Pumps
7. Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
8. Intravenous (IV) Administration of Cempra Pharmaceuticals Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial
9. Selexys Pharmaceuticals Initiates Enrollment in Phase I Clinical Study of SelG1
10. SAR 1118 Demonstrates Encouraging Results in Phase 2 Study of Dry Eye Disease
11. Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)...  Eli Lilly and Company (NYSE: ... study in genetically engineered mice examining combination therapy ... N3pG and beta-secretase inhibitor BACE (LY2811376). Data results ... removing clumps of amyloid-beta protein in the brain ... to Alzheimer,s disease (AD) – than use of ...
(Date:7/11/2014)... 11, 2014  Rock Creek Pharmaceuticals, Inc. (NASDAQ: ... that the Food and Drug Administration ("FDA"), has notified ... RCP,s Investigational New Drug ("IND") application before granting the ... US. Dr. Chris Chapman , RCP,s ... on our IND. When we receive the agency,s official ...
(Date:7/11/2014)... July 11, 2014  Kindred Hospital Houston Northwest, ... the opening of its new outpatient wound healing ... to people with chronic, hard to heal wounds. ... lead to amputation, lower leg wounds related to ... closure, and traumatic injury wounds which are complex ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2
(Date:7/14/2014)... July 14, 2014 TherapySites, ... for mental health professionals, announced today its affiliation ... North Carolina (LPCANC). This new relationship allows ... solutions to LPCANC members, adding exclusive benefits and ... we have been dedicated to providing online marketing ...
(Date:7/14/2014)... EnergyFirst, manufacturer of all-natural ... Permalean for its great products, thriving customer base, ... markets its products as Jim’s Permalean Protein Powders and ... EnergyFirst’s lineup of nutritional products. The Permalean brand ... year. , Founded in 1999, Permalean’s products were designed ...
(Date:7/14/2014)... CT (PRWEB) July 14, 2014 Summer is ... vacations, camping, days at the beach, swimming and other outdoor ... everyone to be safe, happy and healthy all summer long. ... a list of the three must-have custom imprinted products everyone ... summer essential is of course sunblock. Sunscreen helps ...
(Date:7/14/2014)... 14, 2014 New research and analysis ... for the Earth examines toxic ingredients in tampons, ... nationwide, including specific chemicals that may be found in ... fragrances that may put women’s health at risk. ... Alexandra Scranton , the potential impact of toxic ...
(Date:7/14/2014)... Calgary, Alberta, Canada (PRWEB) July 14, 2014 ... the “Trusted Authority in Turning Information into Money,” ... Spotfire® Partner Network, a global program that helps ... or embed the TIBCO Spotfire® analytics platform. TIBCO ... and business intelligence software, including TIBCO Spotfire analytics, ...
Breaking Medicine News(10 mins):Health News:TherapySites Partners With the Licensed Professional Counselors Association of North Carolina to Make Online Marketing Available to All Therapists 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 3Health News:Why These Three Summer Essentials from 4AllPromos Can Improve Summer 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 3Health News:New Patent Analysis Shows Toxic Risk From Tampons 4Health News:New Patent Analysis Shows Toxic Risk From Tampons 5Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 2Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 3
... Noting that health care is one of,the ... have been transformed by,modern, efficient information technology, a ... a health care information technology bill,that has broad ... Commerce Subcommittee on Health,Marc Reed, Verizon executive vice ...
... Forward Campaign rolled out in phases to purchase new 60,000 sq. ft ... ... is facing a,startling threat: Hunger! In the effort to continue its vital mission ... launched a $5 million Growing Forward Campaign to find a new,home. After completing ...
... CHAPEL HILL Non-white defendants are nearly twice as ... in North Carolina criminal cases stemming from inflicted traumatic ... reached by researchers from the Injury Prevention Research Center ... who tracked down what happened in every such case ...
... Co. of,Deerfield, Ill., has agreed to pay $35 ... it improperly switched patients to different versions of ... to,increase its reimbursement from Medicaid, the Justice Department ... pharmacies throughout the,U.S., switched the prescriptions for Medicaid ...
... 4 Edwards Lifesciences,Corporation (NYSE: EW ), ... advanced cardiovascular disease, is scheduled to participate in ... the Ritz-Carlton,Laguna Niguel Hotel in Dana Point, California ... Abate, Edwards Lifesciences, corporate vice president, chief,financial officer ...
... of Clinical Immunology Societies presentations highlight,important findings ... BOSTON, June 4 The Federation of ... awards to two,researchers recognizing significant findings related ... awards will be made following a research ...
Cached Medicine News:Health News:Verizon Executive Urges Congress to Pass Health Care IT Legislation 2Health News:Verizon Executive Urges Congress to Pass Health Care IT Legislation 3Health News:Verizon Executive Urges Congress to Pass Health Care IT Legislation 4Health News:Lowcountry Food Bank On the Way to $5 Million Goal with Over $2.5 Million Raised 2Health News:Lowcountry Food Bank On the Way to $5 Million Goal with Over $2.5 Million Raised 3Health News:Lowcountry Food Bank On the Way to $5 Million Goal with Over $2.5 Million Raised 4Health News:Non-whites receive harsher sentences for inflicted traumatic brain injury of children 2Health News:Non-whites receive harsher sentences for inflicted traumatic brain injury of children 3Health News:Walgreens to Pay $35 Million to U.S., 46 States & Puerto Rico to Settle Medicaid Prescription Drug Fraud Allegations 2Health News:Edwards Lifesciences to Present at the Goldman Sachs 29th Annual Global Healthcare Conference 2Health News:New Diabetes Research To Be Presented at FOCIS Annual Meeting 2Health News:New Diabetes Research To Be Presented at FOCIS Annual Meeting 3
... Saturated Swabsticks are packaged ... foil-laminated pouches. Each 4 ... with precisely the correct ... package is terminally sterilized, ...
... alcohol and 10% povidone iodine formulated ... a barrier on the skin. The ... the povidone iodine, giving persistent protection ... catheter related infections for up to ...
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
... Aplicare's saturated swabsticks are packaged in easy ... inch swabstick is saturated with precisely the ... Gel Swabstick is saturated with a multi-purpose ... gel is also approved for venipuncture site ...
Medicine Products: